Cargando…

Polyurea Dendrimer Folate-Targeted Nanodelivery of l-Buthionine Sulfoximine as a Tool to Tackle Ovarian Cancer Chemoresistance

Ovarian cancer is a highly lethal disease, mainly due to chemoresistance. Our previous studies on metabolic remodeling in ovarian cancer have supported that the reliance on glutathione (GSH) bioavailability is a main adaptive metabolic mechanism, also accounting for chemoresistance to conventional t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Adriana, Mota, Pedro, Ramos, Cristiano, Pires, Rita F., Mendes, Cindy, Silva, José P., Nunes, Sofia C., Bonifácio, Vasco D. B., Serpa, Jacinta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070262/ https://www.ncbi.nlm.nih.gov/pubmed/32028640 http://dx.doi.org/10.3390/antiox9020133

Ejemplares similares

l-Buthionine Sulfoximine Detection and Quantification in Polyurea Dendrimer Nanoformulations
por: Mota, Pedro, et al.
Publicado: (2019)

Targeting Glutathione and Cystathionine β-Synthase in Ovarian Cancer Treatment by Selenium–Chrysin Polyurea Dendrimer Nanoformulation
por: Santos, Inês, et al.
Publicado: (2019)

Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
por: Lee, F. Y., et al.
Publicado: (1987)

Effects of Buthionine Sulfoximine Treatment on Cellular Glutathione Levels and Cytotoxicities of Cisplatin, Carboplatin and Radiation in Human Stomach and Ovarian Cancer Cell Lines(*): – Glutathione, Buthionine Sulfoximine, Cytotoxicity –
por: Lee, Kyung Shik, et al.
Publicado: (1992)

Nifurtimox Is Effective Against Neural Tumor Cells and Is Synergistic with Buthionine Sulfoximine
por: Du, Michael, et al.
Publicado: (2016)

Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
por: Ono, K., et al.
Publicado: (1986)

In vivo production of different chloroform metabolites: effect of phenobarbital and buthionine sulfoximine pretreatment.
por: Gemma, S, et al.
Publicado: (1994)

The responses of Ht22 cells to oxidative stress induced by buthionine sulfoximine (BSO)
por: Chen, Jun, et al.
Publicado: (2005)

3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells
por: Lee, Minjong, et al.
Publicado: (2017)

Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S, et al.
Publicado: (2008)

Enhancement of Antitumor Activity of Cisplatin on Human Gastric Cancer Cells in vitro and in vivo by Buthionine Sulfoximine
por: Saikawa, Yoshiro, et al.
Publicado: (1993)

Glutathione Depletion by L-Buthionine-S,R-Sulfoximine Induces Apoptosis of Cardiomyocytes through Activation of PKC-δ
por: Kim, Young-Ae, et al.
Publicado: (2013)

Protective Effect of Tempol on Buthionine Sulfoximine-Induced Mitochondrial Impairment in Hippocampal Derived HT22 Cells
por: Salvi, Ankita, et al.
Publicado: (2016)

The effects of buthionine sulfoximine treatment on diaphragm contractility and SERCA pump function in adult and middle aged rats
por: Smith, Ian C, et al.
Publicado: (2015)

Correction to: Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis
por: Lewis-Wambi, Joan S., et al.
Publicado: (2018)

The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma
por: Tagde, A, et al.
Publicado: (2014)

Multidrug Resistance-Associated Protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine Sulfoximine
por: Akan, Ilhan, et al.
Publicado: (2005)

Adenosine Improves Mitochondrial Function and Biogenesis in Friedreich’s Ataxia Fibroblasts Following L-Buthionine Sulfoximine-Induced Oxidative Stress
por: Lew, Sze Yuen, et al.
Publicado: (2023)

PKCδ Sensitizes Neuroblastoma Cells to L-Buthionine-Sulfoximine and Etoposide Inducing Reactive Oxygen Species Overproduction and DNA Damage
por: Marengo, Barbara, et al.
Publicado: (2011)

Synergistic Apoptosis of CML Cells by Buthionine Sulfoximine and Hydroxychavicol Correlates with Activation of AIF and GSH-ROS-JNK-ERK-iNOS Pathway
por: Chowdhury, Avik Acharya, et al.
Publicado: (2013)

Iron-based metal-organic framework co-loaded with buthionine sulfoximine and oxaliplatin for enhanced cancer chemo-ferrotherapy via sustainable glutathione elimination
por: Rao, Zhiping, et al.
Publicado: (2023)

BIM(EL) is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine
por: Tanaka, Yukie, et al.
Publicado: (2014)

"Shock and kill" effects of class I-selective histone deacetylase inhibitors in combination with the glutathione synthesis inhibitor buthionine sulfoximine in cell line models for HIV-1 quiescence
por: Savarino, Andrea, et al.
Publicado: (2009)

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE
por: Delbart, Wendy, et al.
Publicado: (2023)

Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo
por: Thomas, Alexandra, et al.
Publicado: (2020)

Synthesis and Transformations of NH‐Sulfoximines
por: Andresini, Michael, et al.
Publicado: (2021)

A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy
por: Lan, Jin-Shuai, et al.
Publicado: (2021)

A Glimpse into Dendrimers Integration in Cancer Imaging and Theranostics
por: Cruz, Adriana, et al.
Publicado: (2023)

Editorial: New strategies to tackle chemoresistance in cancer
por: De Marco, Carmela, et al.
Publicado: (2022)

Systemic L-Buthionine -S-R-Sulfoximine Treatment Increases Plasma NGF and Upregulates L-cys/L-cys2 Transporter and γ-Glutamylcysteine Ligase mRNAs Through the NGF/TrkA/Akt/Nrf2 Pathway in the Striatum
por: Valdovinos-Flores, Cesar, et al.
Publicado: (2019)

Folate-Targeted Transgenic Activity of Dendrimer Functionalized Selenium Nanoparticles In Vitro
por: Pillay, Nikita Simone, et al.
Publicado: (2020)

POxylated Dendrimer‐Based Nano‐in‐Micro Dry Powder Formulations for Inhalation Chemotherapy
por: Restani, Rita B., et al.
Publicado: (2018)

Novel Pieces for the Emerging Picture of Sulfoximines in Drug Discovery: Synthesis and Evaluation of Sulfoximine Analogues of Marketed Drugs and Advanced Clinical Candidates
por: Sirvent, Juan Alberto, et al.
Publicado: (2017)

Silver-mediated Room Temperature Reactions for the Synthesis of N-α-Ketoacyl Sulfoximines and N-α,β-Unsaturated Acyl Sulfoximines
por: Gupta, Ria, et al.
Publicado: (2023)

Cysteine metabolic circuitries: druggable targets in cancer
por: Bonifácio, Vasco D. B., et al.
Publicado: (2020)

Mechanosynthesis of Polyureas and Studies of Their Responses to Anions
por: Al-Ithawi, Wahab K. A., et al.
Publicado: (2023)

Nanodelivery of Dietary Polyphenols for Therapeutic Applications
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Nanodelivery of antiretroviral drugs to nervous tissues
por: Lawal, Sodiq Kolawole, et al.
Publicado: (2022)

Poly(amidoamine) Dendrimer–Methotrexate Conjugates: The Mechanism of Interaction with Folate Binding Protein
por: van Dongen, Mallory A., et al.
Publicado: (2014)

In vitro suppression of inflammatory cytokine response by methionine sulfoximine
por: Peters, Tyler J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cjsi1vionq3vbu2bg825rl1roq